Late-onset familial Mediterranean fever presenting as recurrent fever and polyarthritis in a 41-year-old man: a case report with literature review
Familial Mediterranean fever (FMF) is the most common monogenic autoinflammatory disease, caused by pathogenic variants in the MEFV gene-encoding pyrin, and typically presents before 20 years of age with recurrent episodes of fever and serositis. Late-onset disease is uncommon and may be overlooked, particularly when musculoskeletal manifestations predominate over abdominal symptoms. We report the case of a 41-year-old man who presented with a 1-year history of recurrent febrile, accompanied by generalized body pain, polyarthritis involving both small and large joints, chills, night sweats, and an unintentional 12-kg weight loss. Acute-phase reactants were markedly elevated during attacks and normalized between episodes. Extensive investigations, including computed tomographic angiography, whole-body ^ 18F-fluorodeoxyglucose positron emission tomography, autoantibody testing, and infectious disease screening, excluded systemic vasculitis, malignancy, connective tissue disease, and infection. His sister had recurrent fever and abdominal pain that responded to empirical colchicine for presumed FMF. Whole-exome sequencing identified a heterozygous likely pathogenic MEFV variant, c.2080 A > G (p. Met694Val), in exon 10. Based on the characteristic recurrent inflammatory episodes, positive family history, genetic findings, and fulfillment of the Tel Hashomer/Livneh classification criteria, a diagnosis of late-onset FMF was established. Treatment with colchicine resulted in substantial resolution of recurrent inflammatory attacks and also covers the non-attack manifestations. This case highlights that FMF may first present in the fifth decade of life with recurrent fever and polyarthritis rather than classic serositis. FMF should be considered in adults of Mediterranean or Middle Eastern ancestry with unexplained recurrent inflammatory episodes, even in the fifth decade and when polyarthritis predominates over serositis; a single heterozygous MEFV variant must be interpreted alongside the phenotype, family history, and exclusion of alternatives, as it neither establishes nor excludes the diagnosis.
Authors
- Azam Taghinejad
- Seppo Meri (ORCID: https://orcid.org/0000-0001-9142-501X)
- Dieter Kabelitz (ORCID: https://orcid.org/0000-0002-4160-7103)
- Kurosh Kalantar (ORCID: https://orcid.org/0000-0002-9160-9449)
- Fatemeh Mirzaei
Institutions
- University of Helsinki (FI)
- Shiraz University of Medical Sciences (IR)
- Helsinki University Hospital (FI)
- Christian-Albrechts-Universität zu Kiel (DE)
- University Hospital Schleswig-Holstein (DE)
- Hospital District of Helsinki and Uusimaa (FI)
Publication Details
- Journal
- Journal of Medical Case Reports
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1186/s13256-026-06869-0
- Primary Topic
- Inflammasome and immune disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00